XTAE
CLIS
Market cap6.56bUSD
Jun 18, Last price
23,710.00ILS
1D
2.60%
1Q
-0.38%
Jan 2017
380.64%
Name
Clal Insurance Enterprises Holdings Ltd
Chart & Performance
P/E
26.75
P/S
0.72
EPS
8.86
Div Yield, %
1.06%
Shrs. gr., 5y
7.24%
Rev. gr., 5y
6.29%
Revenues
26.83b
+25.11%
Net income
718m
+226.36%
CFO
1.60b
P
Dividend
Jun 15, 2025251.28033 ILS/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Clal Insurance Enterprises Holdings Ltd., an Israeli firm, delivers a comprehensive array of insurance solutions. Its business operations are structured into three main divisions: Long-Term Savings, Non-Life Insurance, and Health Insurance. The Long-Term Savings division provides life insurance products with associated coverages, various long-term savings programs, and manages pension and provident funds, including those designated for educational purposes. This segment also offers protection against risks such as mortality, impairment, loss of earning capacity, and diverse health-related circumstances. The Non-Life Insurance division encompasses policies for third-party, employer, professional, and product liabilities. It further covers credit and international trade exposures, property damage, vehicle protection, personal injury coverage, and other general insurance lines, alongside issuing guarantees. The Health Insurance division supplies policies for extended care, medical costs, surgical procedures, organ transplants, accidental injuries, international travel, dental services, coverage for foreign laborers, and other specific health protections. Clal Insurance Enterprises Holdings Ltd. was established in 1987 and maintains its headquarters in Tel Aviv-Yafo, Israel.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||